Developing an Individualized Patient Decision Aid for Chronic Coronary Disease Based on the ISCHEMIA Trial: A Mixed-Methods Study
Our novel, patient-centered approach to developing a PDA for CCD with patient-specific outcomes has the potential to rapidly translate clinical trial results to individual patients and support shared decision-making.
Authors
- Christina M. Pacheco (ORCID: https://orcid.org/0000-0002-6288-0221)
- John A. Dodson (ORCID: https://orcid.org/0000-0003-0163-3013)
- John A. Spertus (ORCID: https://orcid.org/0000-0002-2839-2611)
- Ruth Masterson Creber (ORCID: https://orcid.org/0000-0002-4238-9902)
- Stacy L. Farr (ORCID: https://orcid.org/0000-0003-0738-5524)
- Nobuhiro Ikemura (ORCID: https://orcid.org/0000-0002-6347-4460)
- Christine Fuss
- Anezi Uzendu (ORCID: https://orcid.org/0000-0003-0576-7510)
- David J. Maron (ORCID: https://orcid.org/0000-0002-4867-8588)
- Dan Nguyen (ORCID: https://orcid.org/0000-0001-7025-4442)
- Stephanie Pena
- Judith S. Hochman (ORCID: https://orcid.org/0000-0002-5889-5981)
- Carole Decker
Institutions
- Palo Alto University (US)
- Research Medical Center (US)
- NYU Langone Health (US)
- Health Innovations (United States) (US)
- Saint Luke's Hospital (US)
- University of Missouri–Kansas City (US)
- Columbia University (US)
- Stanford University (US)
Publication Details
- Journal
- Circulation Cardiovascular Quality and Outcomes
- Published
- 2024-09-20
- DOI
- https://doi.org/10.1161/circoutcomes.124.010923
- Citations
- 9
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 10.16
Funders
- U.S. Department of Health and Human Services
- Abbott Laboratories
- Amgen
- Philips
- AstraZeneca
- Sunovion
- Arbor Pharmaceuticals
- Omron Healthcare
- National Institutes of Health
- St. Jude Medical
- Abbott Vascular
- National Heart, Lung, and Blood Institute
- National Center for Advancing Translational Sciences